FDA defines biomarker assays development and discovery as a measurable endpoint for indicating a particular disease or any other physiological state of any organism. Read this in depth blog to know more.
https://bitarticles.com/medicins-and-treatment-articles/biomarker-assay-development-and-discovery-to-differentiate-physiological-vs-pathological-conditions/
Copyright 2019 © P-tweets Refunds